chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from the patient's parent on 17/Nov/2005. A two month old male patient received an injection of Menactra, lot number unknown, on 15/Nov/2005. This product is not licensed for administration in this age group. The route and site of administration were unknown. In the evening on the date of vaccination, the patient experienced a fever of 101 degrees Fahrenheit, was irritable, and his thigh was swollen and warm. Per the reporter, the symptoms still persist, but the fever had decreased to 100 degrees Fahrenheit. At the time of this report, the patient had not recovered. Follow-up information received on 14/Feb/2006 from a health care provider. At the time of vaccination, the patient was using hydrocortisone cream for eczema. Prior to being vaccinated on that day, he was diagnosed with oral candidiasis and prescribed Diflucan. It was unknown whether the patient started this medication. The Menactra vaccination was administered intramuscularly in the left thigh (although PCV-7 was ordered). Concomitant vaccinations received on that day included an intramuscular, right thigh, first dose injection of Dtap/IPV/HBV (Pediarix), lot number AC21801211BA and an intramuscular, left thigh, first dose injection of HIB vaccine, lot number 0209R. The reporter indicates that attempts to contact the parents concerning recovery status have been unsuccessful.
Skin sensitivity left torso, abdomen and back 10 days post injection. Rash and blisters appearing left torso abdomen and back 15 days post injection. Valtrex prescribed.
Fever of 102.2, chills, fatigue, and redness and swelling at the site of the injection.
After Nov. shots my daughter became ill - high/low fevers flu like symptoms same day of shot - 2nd day went to doctor walk in  - called dr - again saw doctor. 15 days of illness L second shot - doctor dismissed all symptoms related - same day fever vomiting - 3-4 days (month of home care). fever dropped.
Loss of taste; Headache; Feverish; Chills; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste), HEADACHE (Headache), PYREXIA (Feverish) and CHILLS (Chills) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 003B71A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced AGEUSIA (Loss of taste), HEADACHE (Headache), PYREXIA (Feverish) and CHILLS (Chills). At the time of the report, AGEUSIA (Loss of taste), HEADACHE (Headache), PYREXIA (Feverish) and CHILLS (Chills) outcome was unknown.            Reporter did not allow further contact
p/1st set of vax pt was inconsolable from 5PM-10PM that evening; pt would fall asleep & wake up in 5 minutes & scream; temp was not taken; no subjective warmth noted; no tx given;
Pt brought by mother to the clinic stating that pt had a high fever due to vaccines. Temperature was taken at 6:05 PM, 105.5 (R). Tylenol was given immediately. Pt discharged at 1835.
Pt developed fevers > 103F, severe headache, transaminitis, hypoxia (ultimately requiring 7L/min O2 via nasal cannula), and severe pancytopenia resulting in hospitalization and a bone marrow biopsy w/ flow cytometry (ultimately negative for leukemia/lymphoma). Her symptoms improved with IV decadron> oral prednisone, though cytopenias are now recurring 4/14/21. Pt had a positive ANA to 2.72 (but was taking doxycycline for anaplasmosis- now PCR and AB titers are negative for Anaplasma) and a positive ENA AB, Anti-Ro is high at 8.0. She has no family hx of autoimmune disease. Her infectious work-up for HIV, EBV, CMV, Blastomycosis, Histoplasmosis, Coccidioides, tickborne pathogens, & ricketsial disease is negative.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 2009, the patient was inoculated with ZOSTAVAX as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 2010, the patient was treated for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related.
-Increased Fatigue with sleep changing from an average of 1-3 hours per night times 2.5 years, now sleeping 12+ hours per night as of 5/28/2021.  -Small painful masses of unknown origin behind both knees and on outside of left thigh. -Increased generalized pain.  -episodes of loss of speech.  Mouth will become numb, unable to form words for 1-2 seconds. Occurring 1-4 times per day.  -daily headaches -blurred and double vision - general feeling of unwell, more so than usual.
After I got the vaccine, I walked back to the nurse's station and had a pressure feeling in my neck and face on the same side that the vaccine was given. The pressure turned into a pain in my neck and face, but not my head. I continued to have that pain the whole time and 2 weeks after the vaccine. 12 hours after the vaccine, I became fatigued, ran a temperature of 101.0, and nausea and diarrhea. That went away after 2 days. I had night sweats for 2 weeks after the vaccine. Not during the day, just at night.
Patient received 2nd dose of Pfizer Covid vaccine on 07-12-21 at 0930. Presented to Health Dept on 07-13-21 and reported that he noticed his left axcillary area was swollen around 0830 on the morning of 07-13-21 approximately 24 hours after receiving 2nd dose of Covid vaccine. Nurse noted that left axcillary area was swollen on the inner area closest to chest and directly in the arm pit area. No erythema present on 07-13-21, was slightly tender to touch. Encouraged to use anti-inflammatory meds, watch area, and to seek medical attention if symptoms persisted or becomes worse.
My scalp shingles re-emerged with a vengeance after the second Pfizer dose.  Original shingles in November 2007. My sinus was inflamed.  I had to use ice packs for the pain, which was across the forehead and down to my face cheeks.  It felt like broken glass moving in my face.  I couldn't understand why I was having such a resurgence but then I thought:  This all happened about a week or so after the 2nd dose of Pfizer vaccine.  I didn't at first connect my symptoms with the vaccine because no one had said anything like what I suffered could happen.  My pharmacist said such pre-existing conditions could present and boy did they ever!  I am very reluctant to have a booster in March 2022 when I would be due.  I experience about 2 weeks of horrible scalp and facial pain.
covid; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program, PCV20 Adult Consumer Quant DTC Testing. A 56-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, Solution for injection in pre-filled syringe), via an unspecified route of administration on an unspecified date (Batch/Lot number and expiry date not reported) as  unknown, single for immunization. Medical history and concomitant medications were not reported. The patient reported, "That i might had Prevnar. But it didn't work for me cause of covid", on an unspecified date. Clinical outcome of the events was unknown.  No follow-up attempts are needed. Information about the batch/lot number cannot be obtained. No further information is expected.
Fatigue; This case was reported by a consumer and described the occurrence of fatigue in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was recovered/resolved.   It was unknown if the reporter considered the fatigue to be related to Shingrix.  Additional case details were reported as follows:  The patient self-reported this case. The age at vaccination was not reported. The patient had some fatigue for 12 hours after getting the dose of the shingrix vaccine. The fatigue improved without any intervention.  No health care professional information available for reporting. The reporter did not consent to follow up. No other information was reported.
I work as a security officer for a multi-story office building. About a week after receiving the vaccine I began having a pain in my hip. Normally, my job requires me to walk between 2-4 miles per shift, and I?ve never had problems doing so. But since the vaccine I?ve only been able to walk for about 30 minutes before needing to sit and rest; the pain becomes unbearable. It doesn?t feel like a backache. It feels like a sharp stabbing sensation in my hip/thigh joint when I'm standing or walking. OTC aspirin and IB have had no effect and the problem hasn?t subdued. A dull pain is always there, even at home and when I'm sleeping, but it becomes a major issue at work because of the constant walking. I?m unsure if it?s vaccine related.
Vaccination administered 11/12/2009. Employee noted a numbness of muscles on the right side. A swelling feeling L side of throat then terrible body ache from throat to bottom of foot. Still had when went to bed @ 10:30. Woke up fine.
Three days post vax pt developed an injection site reaction characterized by swelling, redness and itching. The pt also developed vomiting and chills. She was treated with cephalexin and diphenhydramine. On 11/6/00 the pt was seen by MD who noted improvement. The MD added loratadine to her treatment. By 11/17/00 the reaction had resolved. This is 1 of 4 pts from this facility who had an adverse experience following receipt of 2 different lots of Pnu-Imune-23.
This spontaneous report was received from a healthcare professional refers to a 15 year old female patient. The patient's concurrent condition, concomitant medication and medical history were not reported. On an unknown date in October in 2018 (also reported as 3 months ago), the patient was vaccinated with GARDASIL 9 (therapy type, dose, dose unit, frequency, route of administration, lot #, expiry date unspecified) for prophylaxis. On an unknown date in October in 2018 (also reported as 3 months ago), it was reported that the patient was on therapy with an unspecified antibiotic for an unspecified reason (Adverse event). The outcome of adverse event was unknown. Causality assessment was not provided. No product quality complaint (PQC) was involved.
LETHARGY, COUGH, RUNNY NOSE, LOW GRADE FEVER, DIARRHEA, UPSET STOMACH.
ADVERSE EVENT; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced adverse event. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse event was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
This spontaneous case reported by a nurse, describes the occurrence of administered expired product (dose given after 30-BUD) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 025L21B) for COVID-19 immunization. No medical history reported. On Feb 17, 2022, at 9:57 am, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 17, 2022, at 9:57 am, patient administered expired product (dose given after 30-BUD). At the time of the report, administered expired product (dose given after 30-BUD) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. Reportedly, the vial initially stored in refrigerator Jan 17, 2022, at 16:00 (first punctured on Feb 17, 2022, at 09:57), was stored at room temperature after puncture. That vial remained at room temperature 2 hours and 28 minutes prior to first puncture.
Severe headache; chills; muscle aches; arm and neck pain; arm and neck pain; This is a spontaneous report from a contactable consumer (patient herself). A 61-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN9581), via an unspecified route of administration, on 10Feb2021, 04:00PM as single dose in the right arm for COVID-19 immunization at Hospital. Medical history included gastroparesis, gastroesophageal reflux disease (GERD), memory loss. Allergies to medications, food, or other products was reported as yes. The patient was not pregnant at time of vaccination. Prior to vaccination, the patient had been diagnosed with COVID-19. No other vaccines have been administered within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. The patient experienced severe headache, chills, muscle aches, arm and neck pain on 11Feb2021 12:00 PM. No treatment received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected
MENSTRUATION 9 DAYS EARLIER THAN NORMAL; INDIGESTION; DIZZINESS; CHILLS; HEADACHE; FEVER; MUSCLE PAIN; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. Per procedure, no follow-up will be requested for this case. On an unspecified date, the subject experienced menstruation 9 days earlier than normal, indigestion, dizziness, chills, headache, fever, and muscle pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the menstruation 9 days earlier than normal, headache, indigestion, chills, fever, muscle pain and dizziness was not reported. This report was non-serious.
Feel like I have a sunburn; Running a fever; Ache all over; Headache; Very nauseass; This spontaneous case was reported by a consumer and describes the occurrence of SUNBURN (Feel like I have a sunburn), PYREXIA (Running a fever), MYALGIA (Ache all over), HEADACHE (Headache) and NAUSEA (Very nauseass) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SUNBURN (Feel like I have a sunburn), PYREXIA (Running a fever), MYALGIA (Ache all over), HEADACHE (Headache) and NAUSEA (Very nauseass). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, SUNBURN (Feel like I have a sunburn), PYREXIA (Running a fever), MYALGIA (Ache all over), HEADACHE (Headache) and NAUSEA (Very nauseass) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       CONCOMITANT drugs were not provided.   Patient drank lot of water as treatment.   Reporter did not allow further contact
Very sore injection site, chills, fever (100.7), fatigue for about 14 hours starting about 16 hours after injection.; Very sore injection site, chills, fever (100.7), fatigue for about 14 hours starting about 16 hours after injection.; Very sore injection site, chills, fever (100.7), fatigue for about 14 hours starting about 16 hours after injection.; Very sore injection site, chills, fever (100.7), fatigue for about 14 hours starting about 16 hours after injection.; This is a spontaneous report from a contactable consumer. A 54-years-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: Er8735), via an unspecified route of administration, administered in Left Arm on 08Apr2021 16:30 as single dose for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: En6208) for covid-19 immunization. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On 09Apr2021 08:30, It was reported that, very sore injection site, chills, fever (100.7), fatigue for about 14 hours starting about 16 hours after injection. Therapeutic measures was not taken. The outcome of event was recovered/resolved.   No follow-up attempts are needed. No further information is expected.
New onset cardiac palpitations made it difficult to sleep at night. They could be felt during the day as well.
Random loss of balance, first started in mid June, and happens when I am standing still, or walking, or standing and turning.  Numb/tingly fingers mostly on left hand, happens randomly while sitting, standing, and while holding objects, phone, small items. Dropping items in my hand, like hand tools, fork and spoon, glass of water, etc. Racing heart, lasts 2 minutes to 20 minutes, while at rest, or working, and not under stress. Feet and lower legs very cold, and I am not able to get them warmed up without a warm bath or shower or heating pad.
A 43 y.o. female received her first  dose of the COVID 19 vaccination. She was given the Pfizer vaccination in the right deltoid muscle. During her 15 minute waiting period after the injection, the patient began to experience lightheadedness and feeling weak. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. This provider was notified of patient reaction and she was then assessed in the emergency bay area. Monitored patient for severe reaction symptoms, including but not limited to blood pressure abnormality , hypotension, rapid progression of symptoms, respiratory distress, skin changes and tongue swelling. PMH: anxiety and bipolar. Takes Aripiprazole for this. No other medical history reported. ALLERGY REVIEW OF SYSTEMS:  Patient complains of dizziness (lightheaded), Patient denies chills, fever, malaise/fatigue, facial swelling, sore throat, frequent throat clearing, eyes itching, cough, chest tightness, shortness of breath, wheezing, rash, hives, eczema, cysts, itching of skin, abdominal pain, joint pain and headaches. Previous Reactions: none. Vitals -- 02/19/21 0350 02/19/21 1610. BP: 131/77 125/77. Pulse: 89 75. Resp: (!) 22 16. SpO2: 100% 100% Physical Exam--Vitals and nursing note reviewed.  Constitutional -- General: She is not in acute distress.  Appearance -- Normal appearance. She is well-developed. She is not ill-appearing, toxic-appearing or diaphoretic.  HENT:     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: Oropharynx is clear.     Comments: Clear oral airway/intact Eyes:     Conjunctiva/sclera: Conjunctivae normal.  Neck:     Thyroid: No thyromegaly.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal. No respiratory distress.     Breath sounds: Normal breath sounds. No wheezing.  Musculoskeletal -- Cervical back: Neck supple. Skin --  General: Skin is warm and dry.  Capillary Refill: Capillary refill takes less than 2 seconds. Neurological -- General: No focal deficit present. Mental Status: She is alert and oriented to person, place, and time; Gait: Gait normal. Psychiatric -- Mood and Affect: Mood is anxious; Behavior: Behavior normal; Thought Content: Thought content normal; Judgment: Judgment normal. Assessment/Plan -- Treatment included: water and snacks. Follow up response to treatment: good. Patient discharge: Stable to go home and follow up with PCP; Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health). Pt aware of monitoring symptoms at home. Follow up as needed with pcp. Recommend that she eat a snack and hydrate prior to next vaccine #2 of Pfizer.
Patient in to the clinic on 4/9/18 to report a reaction to a vaccine.  Received a Varicella and MMR vaccine on 4/6/18 in the PM. States the reaction started on 4/7/18 in the PM. Back of right arm where the varicella vaccine had been given had localized swelling, redness, and itching. Denies any other complaints. The back of the right upper arm has redness and mild swelling and itching. Instructed the patient that this is a common side effect of vaccination and should subside within a few days. She did not seek out any treatment. Instructed to apply a cool compress to area. Instructed to call her MD/seek medical care if rash were to worsen or not subside. She verbalized her understanding.
A few minutes after the second vaccine was administered patient felt dizzy & blacked out.  I lowered her to the floor where she lay still with eyes staring blankly for a minute.  I called back a nurse (or two) who suggested getting her onto the bed & taking blood pressure.  BP went down, up then normalized over a period of 15-20 mins.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On unknown dates, the patient received three doses of PNEUMOVAX23 (route of administration, anatomical location, lot# and expiration date were not reported) for prophylaxis. On an unknown date, the patient came to the office to receive the fourth dose of PNEUMOVAX23. No adverse effects were reported. Additional information has been requested.
had a strong pain at the site of injection; This is a spontaneous report from a contactable consumer (patient, reported for herself). A female patient of an unspecified age, received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/lot number: EP7533 and expiry dates was not provided), via an unspecified route of administration, on an unknown date, as a single dose for COVID-19 immunisation and latanoprost, form an unknown date, at 2.5 ml once a day for unknown indication. Patient's medical history and concomitant medications were not reported. Patient stated that she had a side effect after the 1st dose of the COVID 19 vaccine, she had a strong pain at the site of injection and it was resolved after 2-3 days. Action taken in response to the event for latanoprost was unknown. Outcome of the event was reported as recovered on an unknown date.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.